AURA 2023 includes data and analyses from 2020–2022 (primarily 2020–2021) from various sources and reports on patterns and trends in antimicrobial use and appropriateness and antimicrobial resistance (AMR) in Australian acute and community healthcare settings.
The Antimicrobial Use and Resistance in Australia (AURA) Surveillance System collects, reviews and analyses data on antimicrobial use and antimicrobial resistance in human health.
This complete version of the Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard describes what each quality statement means for patients and their families, clinicians, and health service organisations, and provides indicators for local monitoring. It includes information about using clinical care standards, and the background and evidence sources for this standard.
The Commission in partnership with Callida Consulting Pty Ltd and Sepsis Australia has developed a strategic analysis report that envisions the future state of sepsis data in Australia and sets out a five-year plan to realise that vision.
This issue includes items on adolescent health and wellbeing, carceral health, and more. Along with the latest from the Patient Experience Journal, BMJ Quality & Safety, International Journal for Quality in Health Care, Health Policy, and JBI Evidence Synthesis. Also included is the latest from the UK’s NICE.
Insights from the national MedicineInsight program show how COPD management compares with aspects of the COPD Clinical Care Standard and COPD-X guidelines.
Join us on International Day of People with Disability for our latest Person-centred care in practice webinar: Inclusive health care for people with intellectual disability.
Join us on International Day of People with Disability for our latest Person-centred care in practice webinar: Inclusive health care for people with intellectual disability.
The Commission is seeking your feedback on the draft National Pathology Standard (formerly known as the Requirements for Medical Pathology Services).
To advise medical imaging providers of the reprocessing requirements for reusable medical devices (RMDs).